REQUEST A DEMO
Total
USD $0.00
Search more companies

Baby Stem Cells SRL (Romania)

Main Activities: Outpatient Care Centers
Full name: Baby Stem Cells SRL Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Baby Stem Cells SRL is based in Romania. The head office is in Bucharest. The enterprise currently operates in the Outpatient Care Centers sector. Baby Stem Cells SRL was incorporated on January 11, 2012. It currently has a total number of 7 (2022) employees. From the latest financial highlights, Baby Stem Cells SRL reported a net sales revenue drop of 26.39% in 2023. Its’ total assets recorded a negative growth of 3.72%. Baby Stem Cells SRL’s net profit margin decreased by 3.71% in 2023.

Headquarters
Strada George Valentin Bibescu Nr. 20
Bucharest; Bucharest; Postal Code: 013943

Contact Details: Purchase the Baby Stem Cells SRL report to view the information.

Basic Information
Total Employees:
Purchase the Baby Stem Cells SRL report to view the information.
Outstanding Shares:
Purchase the Baby Stem Cells SRL report to view the information.
Registered Capital:
Purchase the Baby Stem Cells SRL report to view the information.
Incorporation Date:
January 11, 2012
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
33%
Purchase this report to view the information.
30%
Purchase this report to view the information.
22%
Purchase this report to view the information.
15%
Company Performance
Financial values in the chart are available after Baby Stem Cells SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
-26.39%
Total operating revenue
-25.07%
Operating profit (EBIT)
-35.35%
EBITDA
-31.79%
Net Profit (Loss) for the Period
-50.93%
Total assets
-3.72%
Total equity
9.3%
Operating Profit Margin (ROS)
-1.82%
Net Profit Margin
-3.71%
Return on Equity (ROE)
-31.86%
Quick Ratio
-0.23%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?